CDP-choline Treatment in ATS Users

• Status: Recruiting
• Trial end date: 2022-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is a 12-week, randomized, double-blind, placebo-controlled trial of cytidine-5'-diphosphate choline in amphetamine-type stimulants-using adolescents.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ewha Womans University Mokdong Hospital
• Treatments: Amphetamine; Choline; Cytidine Diphosphate Choline

Criteria

Inclusion Criteria:

• Aged 14-40 years

• Amphetamine (or amphetamine-like) use disorder (DSM-IV-TR)

• Informed consent

• Seeking treatment

Exclusion Criteria:

• Major medical or neurological illnesses

• Psychiatric illnesses requiring hospitalization, prescription of psychotropic medications, or emergency psychiatric interventions

• Current and past diagnosis of a psychotic disorder, bipolar disorder, conduct disorder, or attention-deficit hyperactivity disorder

• Occasional ATS use (less than monthly use)

• IQ of 80 or lower

• Pregnancy or breastfeeding

• Clinically significant suicidal or homicidal ideation

• Substance use disorders (substances other than amphetamine or MA)